- Home
- LNSR vs HBIO Comparison
LNSR vs HBIO Comparison
Compare LNSR & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- HBIO
- Stock Information
- Founded
- LNSR 2004
- HBIO 1901
- Country
- LNSR United States
- HBIO United States
- Employees
- LNSR N/A
- HBIO N/A
- Industry
- LNSR Medical Electronics
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- LNSR Health Care
- HBIO Industrials
- Exchange
- LNSR Nasdaq
- HBIO Nasdaq
- Market Cap
- LNSR 63.4M
- HBIO 61.2M
- IPO Year
- LNSR N/A
- HBIO 2000
- Fundamental
- Price
- LNSR $9.29
- HBIO $0.99
- Analyst Decision
- LNSR
- HBIO
- Analyst Count
- LNSR 0
- HBIO 0
- Target Price
- LNSR N/A
- HBIO N/A
- AVG Volume (30 Days)
- LNSR 107.2K
- HBIO 284.5K
- Earning Date
- LNSR 02-27-2025
- HBIO 03-06-2025
- Dividend Yield
- LNSR N/A
- HBIO N/A
- EPS Growth
- LNSR N/A
- HBIO N/A
- EPS
- LNSR N/A
- HBIO N/A
- Revenue
- LNSR $48,868,000.00
- HBIO $97,732,000.00
- Revenue This Year
- LNSR $25.07
- HBIO N/A
- Revenue Next Year
- LNSR $24.95
- HBIO $4.32
- P/E Ratio
- LNSR N/A
- HBIO N/A
- Revenue Growth
- LNSR 21.29
- HBIO N/A
- 52 Week Low
- LNSR $2.67
- HBIO $0.94
- 52 Week High
- LNSR $12.13
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- LNSR 42.92
- HBIO 16.00
- Support Level
- LNSR $9.66
- HBIO $1.26
- Resistance Level
- LNSR $11.80
- HBIO $1.43
- Average True Range (ATR)
- LNSR 0.95
- HBIO 0.10
- MACD
- LNSR -0.25
- HBIO -0.03
- Stochastic Oscillator
- LNSR 4.38
- HBIO 6.05
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.